FCM
Forester Capital Management Portfolio holdings
AUM
$70.8M
1-Year Return
8.13%
This Quarter Return
+4.98%
1 Year Return
+8.13%
3 Year Return
+33.21%
5 Year Return
–
10 Year Return
–
AUM
$106M
AUM Growth
-$3.45M
(-3.2%)
Cap. Flow
-$3.51M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
42.78%
Holding
59
New
2
Increased
15
Reduced
29
Closed
1
Top Buys
| 1 |
SEP
Spectra Engy Parters Lp
SEP
|
$1.01M |
| 2 |
KT
KT
|
$210K |
| 3 |
Sanofi
SNY
|
$158K |
| 4 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
$130K |
| 5 |
PUB
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
|
$125K |
Top Sells
| 1 |
JAH
JARDEN CORPORATION
JAH
|
$1.49M |
| 2 |
IBM
IBM
|
$1.17M |
| 3 |
Honeywell
HON
|
$741K |
| 4 |
UnitedHealth
UNH
|
$623K |
| 5 |
AutoZone
AZO
|
$508K |
Sector Composition
| 1 | Healthcare | 27.66% |
| 2 | Consumer Staples | 17.06% |
| 3 | Financials | 15.16% |
| 4 | Industrials | 10.1% |
| 5 | Technology | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JCP
26
DELISTED
J.C. Penney Company, Inc.
JCP
| $2.02M | 1.89% |
240,400
-960
| -0.4% | -$8.08K |
|
27
Exxon Mobil
XOM
$466B
| $1.94M | 1.81% |
22,812
-2,740
| -11% | -$233K |
|
28
Gilead Sciences
GILD
$143B
| $1.92M | 1.79% |
19,550
-40
| -0.2% | -$3.92K |
|
29
AT&T
T
$212B
| $1.91M | 1.79% |
77,564
-185
| -0.2% | -$4.56K |
|
30
Halliburton
HAL
$18.8B
| $1.73M | 1.62% |
39,480
-460
| -1% | -$20.2K |
|
31
Merck
MRK
$212B
| $738K | 0.69% |
13,452
-524
| -4% | -$28.7K |
|
|
32
Sanofi
SNY
$113B
| $390K | 0.36% |
7,890
+3,200
| +68% | +$158K |
|
33
Eli Lilly
LLY
$652B
| $348K | 0.32% |
4,785
-861
| -15% | -$62.6K |
|
|
SI
34
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $325K | 0.3% |
3,000
+1,200
| +67% | +$130K |
|
|
PUB
35
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
| $310K | 0.29% |
16,070
+6,500
| +68% | +$125K |
|
36
Diageo
DEO
$61.3B
| $302K | 0.28% |
2,735
+900
| +49% | +$99.4K |
|
37
SAP
SAP
$313B
| $279K | 0.26% |
3,870
+1,200
| +45% | +$86.5K |
|
38
Unilever
UL
$158B
| $237K | 0.22% |
5,690
| – | – |
|
39
GSK
GSK
$81.5B
| $214K | 0.2% |
3,704
+1,520
| +70% | +$87.8K |
|
40
Teva Pharmaceuticals
TEVA
$21.7B
| $214K | 0.2% |
3,430
| – | – |
|
|
41
KT
KT
$9.78B
| $210K | 0.2% |
+16,090
| New | +$210K |
|
42
National Grid
NGG
$69.6B
| $172K | 0.16% |
2,718
| – | – |
|
43
Prudential
PUK
$33.7B
| $172K | 0.16% |
3,547
| – | – |
|
|
NTT
44
DELISTED
Nippon Telegraph & Telephone
NTT
| $162K | 0.15% |
5,260
-2,660
| -34% | -$81.9K |
|
45
TotalEnergies
TTE
$133B
| $146K | 0.14% |
2,930
+1,200
| +69% | +$59.8K |
|
|
AXA
46
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $143K | 0.13% |
5,650
| – | – |
|
47
HSBC
HSBC
$227B
| $135K | 0.13% |
3,569
| – | – |
|
48
Toronto Dominion Bank
TD
$127B
| $135K | 0.13% |
3,140
| – | – |
|
49
AstraZeneca
AZN
$253B
| $109K | 0.1% |
3,200
+1,300
| +68% | +$44.3K |
|
|
BT
50
DELISTED
BT Group plc (ADR)
BT
| $91K | 0.08% |
2,800
| – | – |
|